Patient-reported outcomes (PROs) with durvalumab by PD-L1 expression in unresectable, stage III NSCLC (PACIFIC)

Garassino M., Paz-Ares L., Hui R., Faivre-Finn C., Spira A., Planchard D., ...More

Annals of Oncology, vol.30, 2019 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 30
• Publication Date: 2019
• Doi Number: 10.1093/annonc/mdz094.001
• Journal Name: Annals of Oncology
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Open Archive Collection: AVESIS Open Access Collection
• Istanbul University-Cerrahpasa Affiliated: No